Cite
HARVARD Citation
Ptak, T. et al. (n.d.). Long‐Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5‐Year Results. American journal of gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ptak, T. et al. (n.d.). Long‐Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5‐Year Results. American journal of gastroenterology. p. . [Online].